PAMA

Quest Q2 revenues drop 4% on lower COVID-19 test demand
By LabPulse.com staff writers
The firm said that for the quarter ended June 30, its base diagnostics business revenues rose 3% year-over-year to $2.1 billion from $2.04 billion. However, Quest's Q2 COVID-19 testing revenues dropped 31% year over year to $355 million from $511 million.
July 20, 2022
2020 07 13 21 34 0390 Covid 19 Global Financial Crisis 400
ACLA praises bill to maintain lab services for seniors
By LabPulse.com staff writers
The legislation was penned to offset the 2014 Protecting Access to Medicare Act (PAMA), which has led to significant cuts to payments for routine laboratory tests that guide clinical decision-making.
June 22, 2022
2019 12 23 18 29 8908 Capitol Hill Government 400
Rusckowski to step down as CEO of Quest Diagnostics
By LabPulse.com staff writers
Rusckowski has served as CEO of Quest for more than a decade. Rusckowski will continue to serve on the Quest board of directors as executive chair through March 2023. The transition will be effective November 1, 2022.
February 2, 2022
2020 04 02 20 02 8495 Quest Diagnostics 400
COVID-19 tests drove increase in Medicare spending in 2020
By Leah Sherwood
The HHS Office of Inspector General (OIG) found that total Medicare Part B spending has increased each year for the past five years. COVID-19 tests accounted for approximately 19% of total Medicare Part B spending on lab tests, while utilization of non-COVID-19 tests as a group decreased 15.9% from 2019. Spending on lab tests other than for COVID-19 in 2020 was the lowest it had been in the past five years (no other year prior to the pandemic had a decrease).
January 3, 2022
2021 02 25 23 48 3444 Covid Virus Dna Molecule 400
Natera nabs ADLT status
By LabPulse.com staff writers
The test can monitor treatment and is able to detect cancer recurrence up to two years before conventional imaging, according to the firm.
June 20, 2021
2019 09 16 18 27 8672 Quality Check Mark 400
CMS delays data reporting for labs
By LabPulse.com staff writers
Per the Protecting Access to Medicare Act (PAMA) of 2014, labs are required to report a range of data points for clinical diagnostic laboratory tests that are not advanced assays, including Healthcare Common Procedure Coding System (HCPCS) codes, associated private payor rates, and volume data.
January 16, 2020
2019 10 30 21 49 9027 Cms Building 400
Congress skips surprise billing, passes LAB Act
By Emily Hayes
Per the LAB Act data reporting requirements on payments for lab services associated with the Protecting Access to Medicare Act of 2014 (PAMA) will be delayed for one year. Furthermore, an independent study will be commissioned on data collection and rate setting for lab services.
December 22, 2019
2019 12 23 18 29 8908 Capitol Hill Government 400
Page 1 of 1